Opal V2C® System
FDA Class II Medical Device
CE Class I Medical Device

Capture digital endpoints in clinical trials, both in-clinic and at-home

Those endpoints help sponsors quantify richer insights that deliver meaningful clinical outcomes and transform patient’s lives through better evidence for gait, balance and additional mobility tests.

Opal V2C System offers movement tests across 4 core domains

Power your clinical trial with wearable sensors

Clario’s Opal V2C®️ precision motion monitoring and actigraphy solution is validated across many indications, including Parkinson’s Disease (PD), Multiple Sclerosis (MS), Spinocerebellar Ataxia (SCA), and more.

It enables efficient data capture by:

  • Delivering real-time data through Precision Motion Monitoring (PerfO) of gait, balance and mobility
  • Having pre-configured standard assessments of instrumented tests embedded in software with more than 140 validated outcome measures
  • Providing analytics through our Mobility Lab software platform
  • Guided patient coaching through the assessment procedure

Clario generates the richest evidence for clinical trials

For the past 10 years, more than 1,000 researchers worldwide have used Opal technology to evaluate human movement and patient functional mobility. Our Opal technology has been studied and cited in 700+ peer-reviewed scientific publications. Our expert scientific advisory team has generated a body of evidence with over 45,000 scientific citations.

Opal® Knowledge Base – Scientific Publications

Explore our collection of 700+ peer-reviewed scientific publications featuring the technical and clinical applications of our Opal® System.

Want to learn more? Contact a precision motion specialist today.